(IBHI) iShares iBonds 2029 Term - Ratings and Ratios
High-Yield Bonds, BBB Bonds, 2029 Maturity, Corporate Bonds, USD Bonds
Dividends
| Dividend Yield | 6.80% |
| Yield on Cost 5y | 8.25% |
| Yield CAGR 5y | 17.05% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 4.28% |
| Value at Risk 5%th | 7.16% |
| Relative Tail Risk | 1.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.41 |
| Alpha | -0.19 |
| CAGR/Max DD | 1.63 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.421 |
| Beta | 0.251 |
| Beta Downside | 0.295 |
| Drawdowns 3y | |
|---|---|
| Max DD | 5.73% |
| Mean DD | 0.93% |
| Median DD | 0.52% |
Description: IBHI iShares iBonds 2029 Term October 29, 2025
The iShares iBonds 2029 Term High Yield and Income ETF (BATS: IBHI) tracks an index of U.S.-dollar-denominated, taxable, fixed-rate corporate bonds rated BBB or lower that all mature in 2029. To fully replicate the index, the fund may hold a modest amount of non-U.S. issuers, and because it concentrates on a single maturity window it is classified as a non-diversified, target-maturity ETF.
Key metrics to watch: the fund’s weighted-average yield-to-maturity (currently ~6.2% annualized) reflects the high-yield credit environment, while its average credit spread over Treasuries sits near 400 bps, indicating heightened compensation for credit risk. Economic drivers such as the Federal Reserve’s policy stance on interest rates and the trajectory of corporate default rates in the high-yield segment are the primary determinants of price performance. Sector exposure is tilted toward energy and industrials, which historically dominate the high-yield space and are sensitive to commodity price cycles and infrastructure spending.
For a deeper, data-driven view of how IBHI’s risk-return profile stacks up against comparable target-maturity products, you might explore the analytics on ValueRay.
What is the price of IBHI shares?
Over the past week, the price has changed by +0.12%, over one month by +1.05%, over three months by +1.55% and over the past year by +6.62%.
Is IBHI a buy, sell or hold?
What are the forecasts/targets for the IBHI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 27 | 14.3% |
IBHI Fundamental Data Overview December 03, 2025
Beta = 0.71
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 307.6m USD (307.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 307.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 307.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.94% (E(307.6m)/V(307.6m) * Re(6.94%) + (debt-free company))
Discount Rate = 6.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBHI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle